ストックスクリーナーアプリを入手
9.97
0.40%
-0.06
前日終値:
$9.91
開ける：
$9.91
24時間の取引高:
74,742
Relative Volume:
0.15
時価総額：
$178.28M
収益：
$62.81M
当期純損益:
$-13.75M
株価収益率:
-12.46
EPS:
-0.8
ネットキャッシュフロー:
$153.00K
1週間 パフォーマンス:
-1.79%
1か月 パフォーマンス:
+19.06%
6か月 パフォーマンス:
+57.17%
1年 パフォーマンス:
-9.53%
1日の値動き範囲:
$9.655
$10.19
1週間の範囲:
$9.115
$10.40
52週間の値動き範囲:
$3.78
$14.13
Optimizerx Corp Stock (OPRX) Company Profile
OPRX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
9.94 | 178.28M | 62.81M | -13.75M | 153.00K | -0.80 |
|
VEEV
Veeva Systems Inc
|
236.74 | 37.82B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
58.99 | 10.90B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
61.20 | 8.97B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
90.28 | 7.61B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
40.11 | 6.83B | 906.14M | -52.62M | 89.62M | -0.3621 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-08 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-12-20 | 開始されました | Stephens | Equal-Weight |
| 2024-07-25 | 再開されました | B. Riley Securities | Buy |
| 2024-04-04 | 開始されました | JMP Securities | Mkt Outperform |
| 2024-01-03 | 開始されました | Barclays | Equal Weight |
| 2023-02-02 | 再開されました | B. Riley Securities | Buy |
| 2022-11-01 | 開始されました | Stifel | Buy |
| 2022-07-15 | 開始されました | SVB Leerink | Outperform |
| 2021-10-18 | 再開されました | B. Riley Securities | Buy |
| 2021-04-13 | 開始されました | RBC Capital Mkts | Outperform |
| 2019-01-03 | 開始されました | William Blair | Outperform |
すべてを表示
Optimizerx Corp (OPRX) 最新ニュース
JPMorgan Chase & Co. Purchases 52,169 Shares of OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
OptimizeRx Co. (NASDAQ:OPRX) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
OptimizeRx (OPRX) Projected to Post Earnings on Monday - MarketBeat
Marshall Wace LLP Buys New Shares in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
XTX Topco Ltd Acquires New Shares in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
Connors Investor Services Inc. Has $287,000 Position in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report - The Manila Times
Healthcare Tech Leader OptimizeRx Jumps to Elite 1st Decile in ESG Rating: Key 2025 Report Findings - Stock Titan
Geode Capital Management LLC Has $1.95 Million Stock Holdings in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
Walleye Capital LLC Acquires Shares of 138,575 OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
Press Release Distribution & PR Platform - ACCESS Newswire
OptimizeRx Corp. to Host Conference Call on Q1 2025 Financial Results on May 12, 2025 - Nasdaq
OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET - The Manila Times
Kennedy Capital Management LLC Increases Position in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
Analysts Set OptimizeRx Co. (NASDAQ:OPRX) Target Price at $9.06 - MarketBeat
OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment - The Manila Times
Whetstone Capital Advisors LLC Invests $6.56 Million in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
OptimizeRx Co. (NASDAQ:OPRX) Short Interest Up 22.0% in March - MarketBeat
Is OptimizeRx Corporation (NASDAQ:OPRX) Expensive For A Reason? A Look At Its Intrinsic Value - simplywall.st
Blair William & Co. IL Reduces Stock Position in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
OptimizeRx Co. (NASDAQ:OPRX) Sees Significant Increase in Short Interest - Defense World
OptimizeRx Corporation (NASDAQ:OPRX) is favoured by institutional owners who hold 59% of the company - Yahoo Finance
Bank of New York Mellon Corp Has $426,000 Stock Position in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
OptimizeRx Files $75 Million Mixed Shelf - Marketscreener.com
OptimizeRx Corp Files For Mixed Shelf Of Up To $75 MillionSEC Filing - MarketScreener
OptimizeRx Co. (NASDAQ:OPRX) Director James Paul Lang Purchases 321,408 Shares - MarketBeat
Royce & Associates LP Takes Position in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
OptimizeRx Corp (NASDAQ: OPRX): The Metrics That Matter Right Now - Stocks Register
OptimizeRx Co. (NASDAQ:OPRX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
OptimizeRx Corp SEC 10-K Report - TradingView
OptimizeRx director James Lang purchases $2.44 million in common stock - Investing.com Australia
OptimizeRx director James Lang purchases $2.44 million in common stock By Investing.com - Investing.com South Africa
OptimizeRx (OPRX) to Release Quarterly Earnings on Wednesday - MarketBeat
Q1 Earnings Forecast for OptimizeRx Issued By B. Riley - MarketBeat
Head to Head Review: OptimizeRx (NASDAQ:OPRX) & CFN Enterprises (OTCMKTS:CNFN) - Defense World
Why OptimizeRx Corp. (OPRX) Soared Last Week? - Insider Monkey
OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates - MSN
Roth Capital Predicts OptimizeRx's Q1 Earnings (NASDAQ:OPRX) - MarketBeat
Research Analysts Issue Forecasts for OptimizeRx Q1 Earnings - Defense World
Optimizerx Corp (OPRX) 財務データ
収益
当期純利益
現金流量
EPS
Optimizerx Corp (OPRX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Silvestro Stephen L | Chief Commercial Officer |
Mar 01 '25 |
Option Exercise |
0.00 |
1,928 |
0 |
121,886 |
| Odence-Ford Marion | Chief Legal Officer & CHRO |
Mar 01 '25 |
Option Exercise |
0.00 |
771 |
0 |
70,544 |
| KLEMA CATHY | Director |
Feb 02 '25 |
Option Exercise |
0.00 |
5,109 |
0 |
11,752 |
| Odence-Ford Marion | General Counsel and CCO |
Dec 19 '24 |
Option Exercise |
0.00 |
3,927 |
0 |
28,383 |
| Silvestro Stephen L | Chief Commercial Officer |
Dec 19 '24 |
Option Exercise |
0.00 |
6,546 |
0 |
83,424 |
| Besch Doug | Chief Product Officer |
Dec 19 '24 |
Option Exercise |
0.00 |
1,964 |
0 |
12,160 |
| Stelmakh Edward | CFO/COO |
Dec 19 '24 |
Option Exercise |
0.00 |
5,237 |
0 |
38,603 |
| FEBBO WILLIAM J | CEO |
Dec 12 '24 |
Buy |
5.01 |
20,000 |
100,220 |
601,253 |
| Odence-Ford Marion | General Counsel and CCO |
Nov 08 '24 |
Option Exercise |
0.00 |
1,785 |
0 |
24,980 |
| Stelmakh Edward | CFO/COO |
Oct 11 '24 |
Option Exercise |
0.00 |
8,222 |
0 |
35,432 |
0.67%
0.13%
大文字化:
|
ボリューム (24 時間):